BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33007191)

  • 1. Production of aptamers by cell-SELEX and their applications in cancer biomarker identification.
    Zhao J; He J; Zhong L; Huang Y; Zhao Y
    Discov Med; 2020; 29(158):159-167. PubMed ID: 33007191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer biomarker discovery using DNA aptamers.
    Jin C; Qiu L; Li J; Fu T; Zhang X; Tan W
    Analyst; 2016 Jan; 141(2):461-6. PubMed ID: 26567694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances of aptamer-based clinical applications for the diagnosis and therapy of cancer.
    Zhong Y; Wu P; He J; Zhong L; Zhao Y
    Discov Med; 2020; 29(158):169-180. PubMed ID: 33007192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer protein biomarker discovery based on nucleic acid aptamers.
    Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
    Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-SELEX, an Effective Way to the Discovery of Biomarkers and Unexpected Molecular Events.
    Bing T; Zhang N; Shangguan D
    Adv Biosyst; 2019 Dec; 3(12):e1900193. PubMed ID: 32648677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells.
    Graham JC; Zarbl H
    PLoS One; 2012; 7(4):e36103. PubMed ID: 22536456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aptamers selected by cell-SELEX for application in cancer studies.
    Zhang Y; Chen Y; Han D; Ocsoy I; Tan W
    Bioanalysis; 2010 May; 2(5):907-18. PubMed ID: 20657791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications-The Role of Molecular Dynamics Simulation.
    Jeevanandam J; Tan KX; Danquah MK; Guo H; Turgeson A
    Biotechnol J; 2020 Mar; 15(3):e1900368. PubMed ID: 31840436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing aptamer probes for acute myelogenous leukemia detection and surface protein biomarker discovery.
    Yang M; Jiang G; Li W; Qiu K; Zhang M; Carter CM; Al-Quran SZ; Li Y
    J Hematol Oncol; 2014 Jan; 7():5. PubMed ID: 24405684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
    Fang X; Tan W
    Acc Chem Res; 2010 Jan; 43(1):48-57. PubMed ID: 19751057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in cell-SELEX technology for aptamer selection.
    Kaur H
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2.
    Wu J; Wang C; Li X; Song Y; Wang W; Li C; Hu J; Zhu Z; Li J; Zhang W; Lu Z; Yang CJ
    PLoS One; 2012; 7(9):e46393. PubMed ID: 23029506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.
    Pan Q; Law COK; Yung MMH; Han KC; Pon YL; Lau TCK
    PLoS One; 2018; 13(10):e0198980. PubMed ID: 30303958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches in SELEX: An update to aptamer selection technology.
    Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
    Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-SELEX based selection and optimization of DNA aptamers for specific recognition of human cholangiocarcinoma QBC-939 cells.
    Wan J; Ye L; Yang X; Guo Q; Wang K; Huang Z; Tan Y; Yuan B; Xie Q
    Analyst; 2015 Sep; 140(17):5992-7. PubMed ID: 26181902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer selection and applications for breast cancer diagnostics and therapy.
    Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
    J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.
    Van Simaeys D; López-Colón D; Sefah K; Sutphen R; Jimenez E; Tan W
    PLoS One; 2010 Nov; 5(11):e13770. PubMed ID: 21072169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.